Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 10,248 | 6,603 | 21 | 0 | 0 |
| Cost of Goods | 786 | 442 | 425 | 0 | N/A |
| Gross Profit | 9,462 | 6,161 | -404 | 0 | N/A |
| Operating Expenses | 20,917 | 15,567 | 16,019 | 16,275 | -17,607 |
| Operating Income | -10,669 | -8,964 | -15,998 | -16,275 | 17,606 |
| Interest Expense | 2,744 | 2,287 | 1,075 | 726 | 81 |
| Other Income | 1,321 | -6,026 | -7,048 | 1,074 | -10,199 |
| Pre-tax Income | -12,092 | -17,277 | -24,121 | -15,927 | 7,326 |
| Net Income Continuous | -12,092 | -17,277 | -24,121 | -15,927 | 7,919 |
| Net Income | $-12,092 | $-17,277 | $-24,121 | $-15,927 | $7,919 |
| EPS Basic Total Ops | -0.18 | -0.29 | -0.43 | -0.30 | 0.16 |
| EPS Basic Continuous Ops | -0.19 | -0.29 | -0.43 | -0.30 | 0.19 |
| EPS Diluted Total Ops | -0.18 | -0.29 | -0.43 | -0.30 | 0.16 |
| EPS Diluted Continuous Ops | -0.19 | -0.29 | -0.43 | -0.30 | 0.19 |
| EBITDA(a) | $-10,374 | $-8,704 | $-15,809 | $-16,149 | $17,557 |